Compounds > 1,2-dihydro-2,2,4-trimethylquinoline
Page last updated: 2024-08-20

1,2-dihydro-2,2,4-trimethylquinoline and Anterior Choroidal Artery Infarction

1,2-dihydro-2,2,4-trimethylquinoline has been researched along with Anterior Choroidal Artery Infarction in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Chupandina, EE; Kryl'skii, ED; Medvedeva, SM; Mittova, VO; Popov, SS; Popova, TN; Shikhaliev, KS; Verevkin, AN1

Other Studies

1 other study(ies) available for 1,2-dihydro-2,2,4-trimethylquinoline and Anterior Choroidal Artery Infarction

ArticleYear
1-benzoyl-6-hydroxy-2,2,4-trimethyl-1,2-dihydroquinoline exerts a neuroprotective effect and normalises redox homeostasis in a rat model of cerebral ischemia/reperfusion.
    Metabolic brain disease, 2022, Volume: 37, Issue:4

    Topics: Animals; Antioxidants; Cerebral Infarction; Homeostasis; Inflammation; Neuroprotective Agents; Oxidation-Reduction; Quinolines; Rats; Rats, Wistar; Reperfusion

2022